Followers | 6 |
Posts | 128 |
Boards Moderated | 0 |
Alias Born | 03/04/2015 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$ECOS Close to another move I can feel it
Invest in the ecosystem!
SEC Filings
2HR chart setup with Fibonacci retracements. ECOS price action in this range totally reminds me of USMJ before it ran up 1000%+. Having a real difficult time getting shares @ .0002 as there isn't much liquidity. Watching for a breakout above .0004 since its holding the prior support before the last breakout.
ECOS Technical Analysis Video
$ECOS bids picking up @ .0003
http://www.ecolocap.com/
https://www.sec.gov/cgi-bin/browse-edgar?company=Ecolocap&owner=exclude&action=getcompany
$ECOS Bids picking up, .0003's won't stick around for much longer.
http://www.ecolocap.com/
https://www.sec.gov/cgi-bin/browse-edgar?company=Ecolocap&owner=exclude&action=getcompany
$DLCR Moving HIGHER!
$DLCR
DLCR latest 10Q
acquisition news
$DLCR Moving HIGHER!
$DLCR
DLCR latest 10Q
acquisition news
$DLCR in Play!!
$DLCR
DLCR latest 10Q
acquisition news
Order doesn't matter FYI, trying to stay organized..
1. $MGH $XRA $AUMN
2. $BAA $TGD $EGO
3. $GSS $TRX $PPP
4. $THM $AAU $VGZ
5. $AUY $GFI $LODE
Gold stocks on finviz
$DLCR in Play
$DLCR
DLCR latest 10Q
acquisition news
Order doesn't matter FYI, trying to stay organized..
1. $MGH $XRA $AUMN
2. $BAA $TGD $EGO
3. $GSS $TRX $PPP
4. $THM $AAU $VGZ
5. $AUY $GFI $LODE
Gold stocks on finviz
$DLCR in Play
$DLCR
DLCR latest 10Q
acquisition news
Order doesn't matter FYI, trying to stay organized..
1. $MGH $XRA $AUMN
2. $BAA $TGD $EGO
3. $GSS $TRX $PPP
4. $THM $AAU $VGZ
5. $AUY $GFI $LODE
Gold stocks on finviz
Gold Bounce $DLCR
$DLCR
DLCR latest 10Q
Order doesn't matter FYI, trying to stay organized..
1. $MGH $XRA $AUMN
2. $BAA $TGD $EGO
3. $GSS $TRX $PPP
4. $THM $AAU $VGZ
5. $AUY $GFI $LODE
Gold stocks on finviz
Gold Bouncing $DLCR
$DLCR
DLCR latest 10Q
Order doesn't matter FYI, trying to stay organized..
1. $MGH $XRA $AUMN
2. $BAA $TGD $EGO
3. $GSS $TRX $PPP
4. $THM $AAU $VGZ
5. $AUY $GFI $LODE
Gold stocks on finviz
Gold Bounce $DLCR
$DLCR
DLCR latest 10Q
Order doesn't matter FYI, trying to stay organized..
1. $MGH $XRA $AUMN
2. $BAA $TGD $EGO
3. $GSS $TRX $PPP
4. $THM $AAU $VGZ
5. $AUY $GFI $LODE
Gold stocks on finviz
Gold & $DLCR are SIZZLING
$DLCR
DLCR latest 10Q
Order doesn't matter FYI, trying to stay organized..
1. $MGH $XRA $AUMN
2. $BAA $TGD $EGO
3. $GSS $TRX $PPP
4. $THM $AAU $VGZ
5. $AUY $GFI $LODE
Gold stocks on finviz
Gold & $DLCR are SIZZLING
$DLCR
DLCR latest 10Q
Order doesn't matter FYI, trying to stay organized..
1. $MGH $XRA $AUMN
2. $BAA $TGD $EGO
3. $GSS $TRX $PPP
4. $THM $AAU $VGZ
5. $AUY $GFI $LODE
Gold stocks on finviz
Gold Bounce $DLCR
$DLCR
DLCR latest 10Q
Order doesn't matter FYI, trying to stay organized..
1. $MGH $XRA $AUMN
2. $BAA $TGD $EGO
3. $GSS $TRX $PPP
4. $THM $AAU $VGZ
5. $AUY $GFI $LODE
Gold stocks on finviz
Gold Bounce $DLCR
$DLCR
DLCR latest 10Q
Order doesn't matter FYI, trying to stay organized..
1. $MGH $XRA $AUMN
2. $BAA $TGD $EGO
3. $GSS $TRX $PPP
4. $THM $AAU $VGZ
5. $AUY $GFI $LODE
Gold stocks on finviz
$USMJ .0001
My eye has been spying .0003s+ if your a buyer don't sell your shares for a loss. Be patient & wait for the bid to go higher. Buyers really want to get in @ .0001 DON'T SELL THEM YOUR SHARES, hold them since they could be a 100%+ winner. GLTA I have a good feeling here.. #patience
USMJ goes after a 23 BILLION dollar market.
others on watch $TRTC $SRNA $DLCR $AMRS $NXTD
$USMJ .0001
My eye has been spying .0003s+ if your a buyer don't sell your shares for a loss. Be patient & wait for the bid to go higher. Buyers really want to get in @ .0001 DON'T SELL THEM YOUR SHARES, hold them since they could be a 100%+ winner. GLTA I have a good feeling here.. #patience
USMJ goes after a 23 BILLION dollar market.
others on watch $TRTC $SRNA $DLCR $AMRS $NXTD
Thanks for sharing that, USMJ is about to rip big time like $EFFI
$USMJ .0002's +
My eye has been spying .0003s+ if your a buyer don't sell your shares for a loss. Be patient & wait for the bid to go higher. Buyers really want to get in @ .0001 DON'T SELL THEM YOUR SHARES hold them since they could be a 100%+ winner. GLTA I have a good feeling here.. #patience
USMJ goes after a 23 BILLION dollar market.
$USMJ .0002's
My eye has been spying .0003s+ if your a buyer don't sell your shares for a loss. Be patient & wait for the bid to go higher. Buyers really want to get in @ .0001 DON'T SELL THEM YOUR SHARES hold them since they could be a 100%+ winner. GLTA I have a good feeling here.. #patience
USMJ goes after a 23 BILLION dollar market.
$USMJ .0002
$DLCR
.0018
Their Website
$GTHP solid bottom setup! along with $IDGC
$GTHP . . . . .
The terms of the licensing agreement include $200,000 in near-term cash payments, the potential for up to $1.0 million to pay for advancing U.S. Food and Drug Administration approval for LuViva, funding to secure Chinese regulatory approval of LuViva and a royalty payable to Guided Therapeutics on disposables sold in the territories.
Latest 10Q
$GTHP Volume holding .019's
The terms of the licensing agreement include $200,000 in near-term cash payments, the potential for up to $1.0 million to pay for advancing U.S. Food and Drug Administration approval for LuViva, funding to secure Chinese regulatory approval of LuViva and a royalty payable to Guided Therapeutics on disposables sold in the territories.
Latest 10Q
$GTHP solid bottom setup! along with $IDGC
$GTHP . . . . .
The terms of the licensing agreement include $200,000 in near-term cash payments, the potential for up to $1.0 million to pay for advancing U.S. Food and Drug Administration approval for LuViva, funding to secure Chinese regulatory approval of LuViva and a royalty payable to Guided Therapeutics on disposables sold in the territories.
Latest 10Q
$GTHP solid bottom setup! along with $IDGC
$GTHP . . . . .
The terms of the licensing agreement include $200,000 in near-term cash payments, the potential for up to $1.0 million to pay for advancing U.S. Food and Drug Administration approval for LuViva, funding to secure Chinese regulatory approval of LuViva and a royalty payable to Guided Therapeutics on disposables sold in the territories.
Latest 10Q
$GTHP solid bottom setup!
$GTHP . . . . .
The terms of the licensing agreement include $200,000 in near-term cash payments, the potential for up to $1.0 million to pay for advancing U.S. Food and Drug Administration approval for LuViva, funding to secure Chinese regulatory approval of LuViva and a royalty payable to Guided Therapeutics on disposables sold in the territories.
Latest 10Q
$GTHP . . . . .
The terms of the licensing agreement include $200,000 in near-term cash payments, the potential for up to $1.0 million to pay for advancing U.S. Food and Drug Administration approval for LuViva, funding to secure Chinese regulatory approval of LuViva and a royalty payable to Guided Therapeutics on disposables sold in the territories.
Latest 10Q
$GTHP tight AF...
The terms of the licensing agreement include $200,000 in near-term cash payments, the potential for up to $1.0 million to pay for advancing U.S. Food and Drug Administration approval for LuViva, funding to secure Chinese regulatory approval of LuViva and a royalty payable to Guided Therapeutics on disposables sold in the territories.
Latest 10Q
$GTHP sizzling / bottom feeder
The terms of the licensing agreement include $200,000 in near-term cash payments, the potential for up to $1.0 million to pay for advancing U.S. Food and Drug Administration approval for LuViva, funding to secure Chinese regulatory approval of LuViva and a royalty payable to Guided Therapeutics on disposables sold in the territories.
Latest 10Q
$GTHP sizzling / bottom feeder
The terms of the licensing agreement include $200,000 in near-term cash payments, the potential for up to $1.0 million to pay for advancing U.S. Food and Drug Administration approval for LuViva, funding to secure Chinese regulatory approval of LuViva and a royalty payable to Guided Therapeutics on disposables sold in the territories.
Latest 10Q
$GTHP finally bottomed?
The terms of the licensing agreement include $200,000 in near-term cash payments, the potential for up to $1.0 million to pay for advancing U.S. Food and Drug Administration approval for LuViva, funding to secure Chinese regulatory approval of LuViva and a royalty payable to Guided Therapeutics on disposables sold in the territories.
Latest 10Q
$GTHP solid bottom setup!
The terms of the licensing agreement include $200,000 in near-term cash payments, the potential for up to $1.0 million to pay for advancing U.S. Food and Drug Administration approval for LuViva, funding to secure Chinese regulatory approval of LuViva and a royalty payable to Guided Therapeutics on disposables sold in the territories.
Latest 10Q